High-level results from the DESTINY-Breast09 Phase III trial revealed that ENHERTU® (fam-trastuzumab deruxtecan-nxki), in ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

Immunotherapy let some cancer patients with mismatch repair deficient tumors completely avoid surgery, chemo and radiation, a ...

“With the majority of breast cancer cases historically considered HR positive, HER2 negative, additional treatment options are needed to improve outcomes for patients with metastatic disease ...

In a Q&A, Dr. Nataliya Uboha discussed how difficulty swallowing may signal esophageal cancer, treatment options and ongoing ...

Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR ...

CELEBRITY Big Brother's Trisha Goddard has revealed the "vicious" side effects of the "wonder' cancer drug she's taking that's prolonging her life. Trisha, 67, was diagnosed with terminal breast ...

Faulkner’s general practitioner referred her to the emergency department, where she underwent testing and was diagnosed with a rare type of blood cancer called Acute Myeloid Leukaemia.

WASHINGTON (7News) — The Washington D.C. Firefighters Association is holding screenings for its firefighters who may be at risk for esophageal cancer. April is Esophageal Cancer Awareness Month.